BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  3 Biotech Stocks That Soared Recently

  Three biotech stocks gained over 25 percent last week.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  FDA Makes Changes to Alzheimer’s Clinical Trial Goals Amidst Recent Failures

  Despite the recent dismal news regarding Alzheimer’s drug development, the U.S. Food and Drug Administration (FDA) recently proposed new guidelines for developing drugs for the disease.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Analysts Split Over Buffett’s Backing of Teva Pharma

  Some analysts are scratching their head over Warren Buffet’s investment in Teva Pharma.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 3 Top Biotech Stocks to Consider in February

  Analysts with The Motley Fool looked at three biotech stocks that even biotech-leery investors might consider.

  February 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Eli Lilly and Hanmi Shutter a Failed Phase II RA Trial

  Eli Lilly and its Korean collaborative partner Hanmi stopped a Phase II trial on an experimental rheumatoid arthritis treatment following less-than-stellar interim results.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Novartis Could Put Sandoz U.S. Generic Pills Business on the Auction Block Within a Few Weeks

  Novartis may soon be looking to sell off its generics subsidiary Sandoz.

  February 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• Business

  St. Jude Children’s Research Hospital to develop $412 million advanced research center to propel discovery and scientific breakthroughs

  Designed as an interactive hub of exploration and discovery, the more than 625,000-square-foot center will cultivate transformative research and collaboration and attract scientists and clinicians to St. Jude.

  February 19, 2018

   · 

  4 min read
• GenePOC Launches Its revogene™ Instrument and GBS LB Test in Canada

  GenePOC Inc., member of the Debiopharm Group(TM), is proud to announce the launch in its home market for the revogene instrument and the GenePOC(TM) GBS LB assay.

  February 19, 2018

   · 

  2 min read
• St. Jude Children’s Research Hospital® raises $4.3M

  St. Jude Children’s Research Hospital® raises $4.3M during national radio event.

  February 19, 2018

   · 

  6 min read
• Business

  Clinic Service Corporation Announces Changes to Executive Team

  Clinic Service announces new appointments to its leadership team.

  February 19, 2018

   · 

  1 min read